2011•PubMedRequires access

[Vardenafil (levitra): new aspects of clinical efficacy].

Gamidov Si, Iremashvili Vv, Pavlovichev Aa, O Kh Tazhetdinov

Abstract

Vardenafil (levitra, Bayer Schering Pharna, Germany) is a 5-phosphodiesterase inhibitor which proved highly effective and safe in the treatment of erectile dysfunction. Special techniques were used to study sexual satisfaction of female partners of men treated with vardenafil. It was found that vardenafil raises significantly sexual satisfaction of female partners of men treated with vardenafil and prolongs erection. This is a new aspect of vardenafil efficacy.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Vardenafil, Erectile dysfunction, Clinical efficacy, Medicine, cGMP-specific phosphodiesterase type 5, Pharmacology, Internal medicine, Tadalafil